WORKWEEK

By

Biotech! When Taiwan introduced affordable chip manufacturing, tech firm startups exploded. Now Culture Biosciences is working on the same play for biotech.

Bacteria is the building block for everything from drugs to proteins. But building bioreactors to create bacteria is wildly expensive and a huge block for many startups in the biotech space.

That’s where Culture Biosciences is stepping up to the plate. Building in-house bioreactors and making the technology available to biotech companies through the Cloud, means those companies zero their capital expenditure, freeing up liquidity.

Will Patrick shares with Joe his experience in democratizing bioreactor technology, and how Culture Biosciences is shaping up to become the AWS of the biotech industry.

Follow Will Patrick on:

Twitter: https://twitter.com/wgpatrick

LinkedIn: linkedin.com/in/wgpatrick

Check out the Just Raised newsletter: https://bit.ly/3Ghj2tY

Stay up-to-date on all things Just Raised: https://workweek.com/brand/just-raised/ or follow Joe Sweeny on Twitter: https://twitter.com/JoeySweeny